Ridker Paul M., MacFadyen Jean G., Everett Brendan M., Libby Peter, Thuren Tom, Glyn Robert J., . . . Forster Tamás. (2018). Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: A secondary analysis from the CANTOS randomised controlled trial.
Chicago Style (17th ed.) CitationRidker Paul M., et al. Relationship of C-reactive Protein Reduction to Cardiovascular Event Reduction Following Treatment with Canakinumab: A Secondary Analysis from the CANTOS Randomised Controlled Trial. 2018.
MLA idézésRidker Paul M., et al. Relationship of C-reactive Protein Reduction to Cardiovascular Event Reduction Following Treatment with Canakinumab: A Secondary Analysis from the CANTOS Randomised Controlled Trial. 2018.